Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 2

Molecular Approaches to Chordoma

Kordomaya Moleküler Yaklaşımlar

Pages
201–211
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are required to design effective treatment strategies for chordomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A chordoma originates from remnants of the embryonic notochord and is located along the axial skeleton.
📊
Key Findings & Data:Our understanding on the origin and development of chordomas has increases substantially after the application of molecular biological technology.
💡
Conclusion & Impact:Further studies are required to design effective treatment strategies for chordomas.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A chordoma originates from remnants of the embryonic notochord and is located along the axial skeleton. This is a tumor of the skeleton that is usually low grade and is made of calcified lobules within the bone. This paper aims to review current molecular biological advances on the tumor-biology, diagnosis and treatment of chordomas. Advances in chordoma molecular biology are reviewed under different headings corresponding to various processes of cellular biology. Genetic and molecular biological findings of various study groups and the current take on these findings are summarized. Our understanding on the origin and development of chordomas has increases substantially after the application of molecular biological technology. However, these advancements have not yet resulted in novel and effective treatment strategies. Further studies are required to design effective treatment strategies for chordomas.

Özet

Kordoma, embriyonal notokord kalıntılarından köken alan, aksiyal iskelet boyunca yerleşim gösteren, genellikle düşük dereceli, kalsifiye olmuş ve lobüllerden meydana gelen kemik doku içinde yerleşimli bir iskelet tümörüdür. Bu derlemenin amacı kordoma tümör biyolojisi, tanı ve tedavisi konusunda modern genetik-moleküler biyolojik çalışmaların bulgularını özetlemektir. Kordoma moleküer biyolojisi konusundaki gelişmeler, hücre biyolojisini ilgilendiren farklı başlıklar altında ele alınmıştır. Kordomaların başlangıcında ve ilerlemesinde farklı çalışma gruplarının saptadığı genetik değişimler ve moleküler yolaklar üzerine ortaya çıkan görüşler açıklanmıştır. Kordomanın başlangıcı ve gelişimi konusundaki bilgimiz moleküler biyolojik yöntemlerin kullanımı sonrasında belirgin şekilde artmıştır. Fakat bu bilgi hastalığın daha etkin tedavisini sağlayabilecek noktaya gelmemiştir. Hastalığın daha iyi anlaşılabilmesi ve daha etkin tedavi yöntemlerinin uygulanabilmesi için kordomalardaki moleküler yolakların daha kapsamlı bir şekilde araştırılması gerekmektedir.

🔖

Cite This Article

BAYRAK, Ö. F., KUŞKUCU, A., TÜRE, U., TÜYSÜZ, E. C., TÜRKSOY, Ö., GÜLLÜOĞLU, Ş. (2022). Molecular Approaches to Chordoma. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 2, 201–211. https://ajindex.com/articles/637424

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Akhavan-Sigari R, Gaab MR, Rohde V, Abili M, Ostertag H: Expression of PDGFR-alpha, EGFR and c-MET in spinal chordoma: A series of 52 patients. Anticancer Res 34(2):623- 630, 2014 2. Al-Mefty KK, Pravdenkova S, Sawyer J, Al-Mefty O: Impact of cytogenetic abnormalities on the management of skull base chordomas. J Neurosurg 110(4):715-724, 2009 3. Appleman LJ: MET signaling pathway: A rational target for cancer therapy. J Clin Oncol 29(36):4837-4838, 2011 4. Auger M, Raney B, Callender D, Eifel P, Ordonez NG: Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Pediatr Pathol 14(5):763-770, 1994 5. Aydemir E, Bayrak OF, Sahin F, Atalay B, Kose GT, Ozen M, Sevli S, Dalan AB, Yalvac ME, Dogruluk T, Ture U: Characterization of cancer stem-like cells in chordoma. J Neurosurg 116(4):810-820, 2012 6. Bailey CS, Fisher CG, Boyd MC, Dvorak MF: En bloc marginal excision of a multilevel cervical chordoma. Case report. J Neurosurg Spine 4(5):409-414, 2006 7. Barresi V, Ieni A, Branca G, Tuccari G: Brachyury: A diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers. Dis Markers 2014:514753, 2014 8. Bayrak OF, Aydemir E, Gulluoglu S, Sahin F, Sevli S, Yalvac ME, Acar H, Ozen M: The effects of chemotherapeutic agents on differentiated chordoma cells. J Neurosurg Spine 15(6):620-624, 2011 9. Bayrak OF, Gulluoglu S, Aydemir E, Ture U, Acar H, Atalay B, Demir Z, Sevli S, Creighton CJ, Ittmann M, Sahin F, Ozen M: MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol 115(2):143-151, 2013 10. Bayrakli F, Guney I, Kilic T, Ozek M, Pamir MN: New candidate chromosomal regions for chordoma development. Surg Neurol 68(4):425-430; discussion 430, 2007 11. Beddington RS, Rashbass P, Wilson V: Brachyury-a gene affecting mouse gastrulation and early organogenesis. Dev Suppl 1992:157-165 12. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, MeisKindblom JM: Prognostic factors in chordoma of the sacrum and mobile spine: A study of 39 patients. Cancer 88(9):2122- 2134, 2000 13. Bhadra AK, Casey AT: Familial chordoma. A report of two cases. J Bone Joint Surg Br 88(5):634-636, 2006 14. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4(12):915-925, 2003 15. Brandal P, Bjerkehagen B, Danielsen H, Heim S: Chromosome 7 abnormalities are common in chordomas. Cancer Genet Cytogenet 1